Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
03/2001
03/28/2001EP1086111A1 Sulphur orthophosphate compositions, preparation and use
03/28/2001EP1086108A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
03/28/2001EP1086076A1 Sulfonamide inhibitors of aspartyl protease
03/28/2001EP1086073A1 Method for preparing alkoxyamines from nitroxides
03/28/2001CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
03/28/2001CN1063752C Acrylatye cupro-phosphite compounds
03/28/2001CA2317152A1 Near infrared absorbing compound
03/27/2001US6207868 Based on chiral bidentate phosphine ligands with cyclic ring structures to restrict conformational flexibility, asymmetric synthesis of alcohols by enantioselective hydrogenation of ketones catalyzed by the chiral ligands
03/27/2001US6207864 Halogenation of cyclopropylmethyl ketone using dihalo-triorganophosphoranes, dehydrohalogenation of said halogenation products.
03/27/2001US6207819 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
03/27/2001US6207716 Non-steroidal ligands for the estrogen receptor
03/27/2001US6207655 Antitumor activity against multiple myeloma
03/27/2001CA1341210C Synthesis of 1,2-dioxetanes and intermediates therefor
03/22/2001WO2001019838A1 Macrocyclic chelants for metallopharmaceuticals
03/22/2001WO2001019837A1 An improved regiospecific synthesis of phosphonous acids
03/22/2001WO2001019836A1 Phosphonic acid derivatives having carboxypeptidase b inhibitory activity
03/22/2001WO2001019835A1 Formation of oligomeric organophosphorus compositions with improved color
03/22/2001WO2001019829A2 Pyrazolopyrimidines as therapeutic agents
03/22/2001WO2001019828A2 Kinase inhibitors as therapeutic agents
03/22/2001WO2001019820A1 Substituted pyrazol-3-ylbenzoxazinones
03/22/2001WO2001019802A1 Aromatic nitrogenous six-membered ring compounds
03/22/2001WO2001019794A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
03/22/2001WO2001019792A1 Covalently linked dimeric dna binding molecules
03/22/2001WO2001019776A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
03/22/2001WO2001019512A1 Hydrocarbyl phosphinimine/cyclopentadienyl complexes of group 4 and their use in olefin polymerization
03/22/2001WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs
03/22/2001WO2000078763A3 Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
03/22/2001WO2000063195A8 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
03/22/2001CA2385769A1 Kinase inhibitors as therapeutic agents
03/22/2001CA2385747A1 Pyrazolopyrimidines as therapeutic agents
03/22/2001CA2384267A1 Formation of oligomeric or organophosphorus compositions with improved color
03/22/2001CA2383988A1 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
03/22/2001CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs
03/22/2001CA2382057A1 Macrocyclic chelants for metallopharmaceuticals
03/21/2001EP1085371A1 Photographic material containing a novel hydrazide type
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1084152A1 Tridentate ligand-containing metal catalyst complexes for olefin polymerization
03/21/2001EP1084134A1 Activators for oligonucleotide synthesis
03/21/2001EP1084131A1 Organophosphorus compounds for dental polymerizable compositions
03/21/2001EP1083889A2 Method for treating neurodegenerative disorders
03/21/2001EP1030855A4 Bismuth amide compounds and compositions, and method of forming bismuth-containing films therewith
03/21/2001EP0799250B1 Process for the production of polyolefines in the presence of catalyst systems containing azametalloces and catalyst systems containing azametallocenes
03/21/2001EP0716091B1 Tris(substituted phenyl)bismuth derivative
03/21/2001CN1288462A Oxazolidinone combinatorial libraries, compositions and method of prepn.
03/21/2001CN1288009A Method for prepn. of N-phosphonyl methyl amino carboxylic acid
03/21/2001CN1288008A Sulfur-bearing phospho acid compound, pharmaceutical composite and use in prepn. of medicine
03/21/2001CN1063448C Process for preparation of DOP-containing mixture
03/20/2001US6204414 Intermediate compound (5-[2-hydroxy-5-(1-hydroxy-1-methylethyl)-2-methyl-cyclopentyl]-3-methyl-penta-2,4-dienyl) triphenylphos-phosphonium salt, for making metabolites of lycopene
03/20/2001US6204404 Reacting phosphorus trihalide with alcohol
03/20/2001US6204361 Method of peptide synthesis
03/20/2001US6204339 Elastomeric composition comprising a blocked mercaptosilane coupling agent and a deblocking agent
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204292 Bicyclic metabotropic glutamate receptor ligands
03/20/2001US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors
03/20/2001US6204257 Drug delivery
03/15/2001WO2001018548A2 Protecting alkylating reagents used for quantifying homocysteine
03/15/2001WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001WO2001018106A1 Flame-resistant polycarbonate moulding materials
03/15/2001WO2001018105A1 Flame-resistant polycarbonate abs blends
03/15/2001WO2001018013A1 Prodrugs for liver specific drug delivery
03/15/2001WO2001018012A1 Electronically tuned ligands
03/15/2001WO2001018011A1 Calcium complex of phosphorus containing ethylenediamine derivatives
03/15/2001WO2001017996A1 1,2,3-thiadiazoles and their use as cox-2 inhibitors
03/15/2001WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives
03/15/2001WO1999065870A3 Sulfonamide inhibitors of aspartyl protease
03/15/2001DE19944893A1 Calcium-Komplex von [[(4R)4-[(carboxy-.kappa.O)methyl]amino-. Calcium complex of [[(4R) -4 - [(carboxy-.kappa.O) methyl] amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl] -1-[(4,4-diphenylcyclohexyl)9oxy]-1-hydroxy-2-oxa -6,9-diaza-1-phophaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Therapie und als Zusatzstoff in der Diagnostik sowie Verfahren zur Herstellung der Komplexe und Mittel #### kappa.N] -6,9-bis [(carboxy-.kappa.O) methyl] -1 - [(4,4-diphenylcyclohexyl) 9oxy] -1-hydroxy-2-oxa-6.9-diaza-1 -phophaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.O11] 1-oxidato (6 -)] -, hexahydrogen, its salts, pharmaceutical agents containing these complexes, their use in therapy and as an additive in the diagnosis and methods for producing the complexes and agents ####
03/15/2001CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001CA2383681A1 Flame-resistant polycarbonate moulding materials
03/15/2001CA2383648A1 Flame-resistant polycarbonate abs blends
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1082362A1 Supported group 8-10 transition metal olefin polymerization catalysts
03/14/2001EP1082331A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
03/14/2001EP1082328A1 Production of optically active phospholanes
03/14/2001EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
03/14/2001EP0769015B1 Phosphonic acid compounds, their production and use
03/14/2001CN1287557A Electrochemical synthesis of perfluoroalkylfluorophosphoranes
03/14/2001CN1287021A Compound phase-transferring quaternary ammonium salt catalyst in beta-hydroxyl structure and its preparation
03/14/2001CN1063182C Aminophenylphosphonic acid compounds, process for preparing them and medical composition containing them
03/14/2001CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
03/13/2001US6201148 Process for preparing alendronic acid
03/13/2001US6200932 As pesticide and herbicide
03/13/2001US6200925 As polymerization catalyst
03/08/2001WO2001017211A2 Communications system
03/08/2001WO2001016260A1 Oligomeric polyketones
03/08/2001WO2001016143A1 Solvent-free method for preparing sterically hindered phosphoramidates
03/08/2001WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
03/08/2001WO2001016090A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
03/08/2001DE19941826A1 Flammwidrige Polycarbonat-Formmassen A flame-resistant polycarbonate molding compositions
03/08/2001DE19941821A1 Flammwidrige Polycarbonat-ABS-Blends The flame-retardant polycarbonate-ABS blends
03/08/2001DE19941566A1 Stabile (CF3)2N-Salze und Verfahren zu deren Herstellung Stable (CF3) 2N salts and processes for their preparation
03/08/2001DE10033956A1 Production of bis(phosphino/arsino-) compounds, useful as chelate ligands for transition metal catalysts, comprises reaction of an alkylene sulfate with alkali metal phosphine or arsine compounds.
03/08/2001DE10033955A1 Production of bis-phosphino or -arsino compounds, used as chelating ligands for transition metals, involves reacting di-halo compound with two benzyl-diorganyl-element compounds and hydrogenating the product
03/08/2001CA2387507A1 Communications system
03/08/2001CA2384191A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
03/07/2001EP1081154A2 Materials and methods for growing complex perovskite oxide thin films
03/07/2001EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides
03/07/2001EP1081129A2 Stable (CF3)2N-Salts, a method of preparing them and their use in the synthesis of liquid crystals
03/07/2001EP1080096A1 Novel furylphosphines and organometallic complexes containing them
03/07/2001EP1080089A1 Pyrazolyldioxothiochromanoyl derivatives
03/07/2001EP1025110A4 Weakly coordinating anions containing polyfluoroalkoxide ligands